BAG3 regulates Rab35 and the ESCRT/endolysosome pathway
BAG3 regulates Rab35 and the ESCRT/endolysosome pathway
批准号:
10667539
负责人:
Gail V. W. Johnson
金额:
$43.63万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-08-15 至 2026-06-30
关键词:
AftercareAlzheimer&aposs DiseaseAreaAutophagocytosisAwarenessBCL2 geneBindingClientDNA cassetteDataDendritic SpinesDevelopmentDiseaseEndosomesEnterobacteria phage P1 Cre recombinaseEstersEventFunctional disorderGTPase-Activating ProteinsHealthHomeostasisInjectionsInvestigationKineticsLeucineLoxP-flanked alleleLysosomesMaintenanceMediatingMediatorMolecularMorphologyMusNeurodegenerative DisordersNeuronsOutcomePathogenesisPathologicPathologyPathway interactionsPatternPhysiological ProcessesPlayPopulationProcessProteinsProteomeProteomicsQuality ControlReactive Oxygen SpeciesRegulationReportingResistanceRoleSignal TransductionSortingStressStructureSynapsesSystemTamoxifenTertiary Protein StructureTestingVesiclehigh resolution imagingin vivoinnovationinsightlive cell imagingmouse modelnoveloptogeneticsoverexpressionpromoterprotein aggregationproteostasisrecruitrepairedtau Proteinstau aggregationtau expressiontau-1trafficking
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Protein quality control systems are essential for maintaining neuronal health, with vacuolar dependent pathways
playing a primary role in these systems. The endolysosome system is a major contributor to the maintenance of
the neuronal proteome, and dysfunction of this system occurs early in the pathogenesis of Alzheimer’s disease
(AD) , and likely contributes to the accumulation and mislocalization of tau, which plays a key role in disease
pathogenesis. Recent data provide compelling evidence that the stress responsive, multi-domain protein, Bcl-2-
associated anthogene 3 (BAG3) plays a role in maintaining protein homeostasis and neuronal health. The
expression of BAG3 in specific neuronal populations positively correlates with resistance to the development of
tau pathology in AD. Further, our preliminary data indicate that BAG3 is an upstream regulator of vacuolar
dependent pathways. The UNDERLYING PREMISE of this proposal is that in neurons, BAG3 plays a critical
role in mediating vacuolar dependent pathways, and thus proteostasis and neuronal integrity. The importance
of BAG3 in mediating proteostasis is illustrated by the fact that BAG3 not only plays an important role in protecting
neurons from the accumulation of pathological tau species, but also likely supports synaptic structure.
Nonetheless, our understanding of the mechanisms by which BAG3 regulates vacuolar dependent processes is
very limited. Although previous studies have implicated BAG3 as a mediator of autophagy, we are the first to
present evidence that BAG3 is a regulator of the endolysosome pathway. Further, our preliminary findings
implicate BAG3 as an important modulator of endosomal sorting required for transport (ESCRT) machinery.
BAG3 interacts withTBC1D10B, the primary GTPase activating protein (GAP) for Rab35, which facilitates the
recruitment of the ESCRT machinery and protein clients to the endosome, as well as mediating other vacuolar
dependent processes. The conceptual framework that BAG3 acts upstream of vacuolar pathways through its
regulation of Rab35 activity is novel and innovative. The OVERALL HYPOTHESIS of this proposal is that the
BAG3-TBC1D10B-Rab35 signaling axis regulates endosome-lysosome function and neuronal health. In
the context of this overall hypothesis the specific aims of this proposal are: to test the hypotheses that: (1) the
BAG3-TBC1D10B-Rab35 signaling axis regulates ESCRT and the endolysosome pathway, (2) in vivo BAG3
and Rab35 coordinate to mediate neuronal ESCRT/vacuolar processes, and contribute to the maintenance
synaptic integrity, and (3) the BAG3-TBC1D10B-Rab35 axis plays a critical role in regulating the clearance of
pathological tau species. These studies will be carried out using mouse models and primary neuron cultures.
The IMPACT of these studies is that they will provide crucial new insights into the mechanisms by which BAG3
acts as an upstream mediator of the endolysosome systems to maintain a healthy neuron. Overall these studies
represent a new, unexplored area of investigation that will increase our understanding of the factors that are
essential to maintain a healthy, functional neuronal proteome.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1002/jcb.29952
发表时间:
2022-01
期刊:
Journal of cellular biochemistry
影响因子:
4
作者:
[Lin H, Koren SA, Cvetojevic G, Girardi P, Johnson GVW]
通讯作者:
Johnson GVW
Mitochondrial dysfunction and tau pathology in Alzheimer's disease
-
批准号:10805120
-
项目类别:
-
资助金额:$42.35万
-
财政年份:2023
-
负责人:Gail V. W. Johnson
-
依托单位:
Mechanisms of Transglutaminase 2 (TG2)-Mediated Gene Expression in Astrocyte
-
批准号:10293984
-
项目类别:
-
资助金额:$42.35万
-
财政年份:2021
-
负责人:Gail V. W. Johnson
-
依托单位:
BAG3 regulates Rab35 and the ESCRT/endolysosome pathway
-
批准号:10269305
-
项目类别:
-
资助金额:$43.63万
-
财政年份:2021
-
负责人:Gail V. W. Johnson
-
依托单位:
BAG3 regulates Rab35 and the ESCRT/endolysosome pathway
-
批准号:10461933
-
项目类别:
-
资助金额:$43.63万
-
财政年份:2021
-
负责人:Gail V. W. Johnson
-
依托单位:
Tau Post-Translational Modifications and Mitochondrial Quality Control
-
批准号:10374933
-
项目类别:
-
资助金额:$57.09万
-
财政年份:2020
-
负责人:Gail V. W. Johnson
-
依托单位:
Tau Post-Translational Modifications and Mitochondrial Quality Control
-
批准号:10188394
-
项目类别:
-
资助金额:$57.09万
-
财政年份:2020
-
负责人:Gail V. W. Johnson
-
依托单位:
Tau Post-Translational Modifications and Mitochondrial Quality Control
-
批准号:10601125
-
项目类别:
-
资助金额:$57.09万
-
财政年份:2020
-
负责人:Gail V. W. Johnson
-
依托单位:
Tau protein turnover and mitochondrial stress responses
-
批准号:9761421
-
项目类别:
-
资助金额:$23.1万
-
财政年份:2018
-
负责人:Gail V. W. Johnson
-
依托单位:
The degradation of tau by selective autophagy
-
批准号:9395850
-
项目类别:
-
资助金额:$33.69万
-
财政年份:2017
-
负责人:Gail V. W. Johnson
-
依托单位:
The degradation of tau by selective autophagy
-
批准号:9918995
-
项目类别:
-
资助金额:$39.68万
-
财政年份:2017
-
负责人:Gail V. W. Johnson
-
依托单位:
The attenuation of ischemic injury by transglutaminase 2
-
批准号:8652526
-
项目类别:
-
资助金额:$2.57万
-
财政年份:2013
-
负责人:Gail V. W. Johnson
-
依托单位:
Autophagy, p62 and the Nrf2 Intersect to Protect Against Tau Toxicity
-
批准号:8463265
-
项目类别:
-
资助金额:$18.64万
-
财政年份:2012
-
负责人:Gail V. W. Johnson
-
依托单位:
Autophagy, p62 and the Nrf2 Intersect to Protect Against Tau Toxicity
-
批准号:8369614
-
项目类别:
-
资助金额:$23.18万
-
财政年份:2012
-
负责人:Gail V. W. Johnson
-
依托单位:
The attenuation of ischemic injury by transglutaminase 2
-
批准号:8184138
-
项目类别:
-
资助金额:$33.74万
-
财政年份:2011
-
负责人:Gail V. W. Johnson
-
依托单位:
The attenuation of ischemic injury by transglutaminase 2
-
批准号:8401144
-
项目类别:
-
资助金额:$32.61万
-
财政年份:2011
-
负责人:Gail V. W. Johnson
-
依托单位:
The attenuation of ischemic injury by transglutaminase 2
-
批准号:8260315
-
项目类别:
-
资助金额:$33.8万
-
财政年份:2011
-
负责人:Gail V. W. Johnson
-
依托单位:
The attenuation of ischemic injury by transglutaminase 2
-
批准号:8603292
-
项目类别:
-
资助金额:$38.54万
-
财政年份:2011
-
负责人:Gail V. W. Johnson
-
依托单位:
Posttranslational processing of tau: function & dysfunc.
-
批准号:6897351
-
项目类别:
-
资助金额:$26.86万
-
财政年份:2005
-
负责人:Gail V. W. Johnson
-
依托单位:
Core--Molecular detection
-
批准号:7090250
-
项目类别:
-
资助金额:$20.36万
-
财政年份:2005
-
负责人:Gail V. W. Johnson
-
依托单位:
Posttranslational processing of tau: function & dysfunc.
-
批准号:7454783
-
项目类别:
-
资助金额:$12.45万
-
财政年份:2005
-
负责人:Gail V. W. Johnson
-
依托单位: